![]() |
Volumn 88, Issue 3, 2001, Pages 265-269
|
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
ATORVASTATIN;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
PRAVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG TARGETING;
HIGH RISK POPULATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TITRIMETRY;
TRIACYLGLYCEROL BLOOD LEVEL;
ANTICHOLESTEREMIC AGENTS;
APOLIPOPROTEINS B;
CHOLESTEROL;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
TIME FACTORS;
TRIGLYCERIDES;
|
EID: 0035423181
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)01638-1 Document Type: Article |
Times cited : (168)
|
References (9)
|